Target intelligence / Profile preview

Tumor Antigen

Molecular classification
Protein, Glycoprotein, Peptide
01

Overview

A tumor antigen is an antigenic substance produced by tumor cells that can trigger an immune response in the host. These antigens are either unique to cancer cells or are present at much higher levels in tumors compared to normal tissues, making them useful as both diagnostic markers and therapeutic targets. They are broadly classified into tumor-specific antigens (TSAs) and tumor-associated antigens (TAAs). TSAs are unique to tumor cells and often arise from mutations, while TAAs are present at elevated levels on tumor cells but may also be expressed at lower levels on some normal tissues.

02

Mechanism of action

Targeting tumor cells for destruction via antibody-mediated cytotoxicity, immune cell activation, or drug delivery.

03

Biological functions

Immune responseImmunosurveillanceAntigen presentation
04

Disease associations

Cancer
05

Safety considerations

Off-target toxicity due to expression in normal tissues.Immune-related adverse events.Tumor heterogeneity and antigen escape.Development of resistance.
06

Interacting drugs

Antibody-drug conjugates (ADCs)

3 more in the full profile.

07

Biomarkers

HER2TROP2Nectin‑4Folate Receptor Alpha (FRα)

Beyond the preview

Go deeper on Tumor Antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor Antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call